The Synthetic Triterpenoid, CDDO, Suppresses Alloreactive T Cell Responses and Reduces Murine Early Acute Graft-versus-Host Disease Mortality

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 5, 2007, Pages 521-529

  Sun, Kai ^a   Li, Minghui ^a   Konopleva, Marina ^b   Konoplev, Sergej ^b   Stephens, L Clifton ^b   Kornblau, Steven M ^b   Frolova, Olga ^b   Wilkins, Danice E C ^a   Ma, Weihong ^a   Welniak, Lisbeth A ^a   Andreeff, Michael ^b   Murphy, William J ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Allogeneic hematopoietic stem cell transplantation (allo HSCT); Mixed lymphocyte responses

Indexed keywords

2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 OIC ACID; TRITERPENOID;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; IN VITRO STUDY; LIVER DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROCHIMERISM; MIXED LYMPHOCYTE REACTION; MORTALITY; MOUSE; NONHUMAN; SURVIVAL TIME; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; DISEASE MODELS, ANIMAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLEANOLIC ACID; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247155249     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.12.453     Document Type: Article

References (24)

1. Fowler D.H. Shared biology of GVHD and GVT effects: potential methods of separation. Crit Rev Oncol Hematol. 57 (2006) 225-244
2. Murphy G.F., and Korngold R. Significance of selectively targeted apoptotic rete cells in graft-versus-host disease. Biol Blood Marrow Transplant 10 (2004) 357-365
3. Blazar B.R., and Murphy W.J. Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci. 360 (2005) 1747-1767
4. Ferrara J.L., and Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol. 43 (2006) 3-10
5. Ray D.M., Morse K.M., Hilchey S.P., et al. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway. Exp Hematol. 34 (2006) 1201-1210
6. Konopleva M., Tsao T., Estrov Z., et al. The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia. Cancer Res. 64 (2004) 7927-7935
7. Ikeda T., Nakata Y., Kimura F., et al. Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid. Mol Cancer Ther. 3 (2004) 39-45
8. Suh W.S., Kim Y.S., Schimmer A.D., et al. Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL. Leukemia 17 (2003) 2122-2129
9. Chintharlapalli S., Papineni S., Konopleva M., et al. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways. Mol Pharmacol. 68 (2005) 119-128
10. Nakajima A., Wada K., Miki H., et al. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120 (2001) 460-469
11. Schmidt S., Moric E., Schmidt M., et al. Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients. J Leukoc Biol. 75 (2004) 478-485
12. Rollins M.D., Sudarshan S., Firpo M.A., et al. Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. J Gastrointest Surg. 10 (2006) 1120-1130
13. Minns L.A., Buzoni-Gatel D., Ely K.H., et al. A novel triterpenoid induces transforming growth factor beta production by intraepithelial lymphocytes to prevent ileitis. Gastroenterology 127 (2004) 119-126
14. Li J., Helm K., and Howell C.D. Contributions of donor CD4 and CD8 cells to liver injury during murine graft-versus-host disease. Transplantation 62 (1996) 1621-1628
15. Suh N., Wang Y., Honda T., et al. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res. 59 (1999) 336-341
16. Honda T., Rounds B.V., Gribble G.W., et al. Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages. Bioorg Med Chem Lett. 8 (1998) 2711-2714
17. Stadheim T.A., Suh N., Ganju N., et al. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells. J Biol Chem. 277 (2002) 16448-16455
18. Banovic T., MacDonald K.P., Morris E.S., et al. TGF-beta in allogeneic stem cell transplantation: friend or foe?. Blood 106 (2005) 2206-2214
19. Kleinclauss F., Perruche S., Masson E., et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ. 13 (2006) 41-52
20. Place A.E., Suh N., Williams C.R., et al. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Clin Cancer Res. 9 (2003) 2798-2806
21. Vodanovic-Jankovic S., Hari P., Jacobs P., et al. NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145. Blood 107 (2006) 827-834
22. Sun K., Wilkins D.E., Anver M.R., et al. Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity. Blood 106 (2005) 3293-3299
23. Hill G.R., Crawford J.M., Cooke K.R., et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90 (1997) 3204-3213
24. Chen L.W., Egan L., Li Z.W., et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med. 9 (2003) 575-581